Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study. [electronic resource] by
- Ackland, S P
- Anton, A
- Breitbach, G P
- Colajori, E
- Tursi, J M
- Delfino, C
- Efremidis, A
- Ezzat, A
- Fittipaldo, A
- Kolaric, K
- Lopez, M
- Viaro, D
Producer: 20010412
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 19
Availability: No items available.
|
|
8.
|
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. [electronic resource] by
- Coombes, R C
- Kilburn, L S
- Snowdon, C F
- Paridaens, R
- Coleman, R E
- Jones, S E
- Jassem, J
- Van de Velde, C J H
- Delozier, T
- Alvarez, I
- Del Mastro, L
- Ortmann, O
- Diedrich, K
- Coates, A S
- Bajetta, E
- Holmberg, S B
- Dodwell, D
- Mickiewicz, E
- Andersen, J
- Lønning, P E
- Cocconi, G
- Forbes, J
- Castiglione, M
- Stuart, N
- Stewart, A
- Fallowfield, L J
- Bertelli, G
- Hall, E
- Bogle, R G
- Carpentieri, M
- Colajori, E
- Subar, M
- Ireland, E
- Bliss, J M
Producer: 20070301
In:
Lancet (London, England) vol. 369
Availability: No items available.
|